Virtu KCG Holdings’s Kazia Therapeutics KZIA Stock Holding History

Virtu KCG Holdings’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-119	Closed	-$46K	–	3621
2016 Q3	$46K	Buy	+119	New	+$46.4K	﹤0.01%	2797
2015 Q3	–	Sell	-162	Closed	-$130K	–	3611
2015 Q2	$130K	Buy	+162	New	+$184K	﹤0.01%	2813
2015 Q1	–	Sell	-74	Closed	-$31K	–	3538
2014 Q4	$31K	Buy	+74	New	+$36.7K	﹤0.01%	3537
2014 Q1	–	Sell	-73	Closed	-$62K	–	3813
2013 Q4	$62K	Buy	+73	New	+$70.3K	﹤0.01%	3555

Other funds holding KZIA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's KZIA Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Kazia Therapeutics (KZIA) in Q4 2016, closing a stake of 119 shares — an estimated $46K sold.

Virtu KCG Holdings first reported a position in KZIA in Q4 2013 and held it in 4 quarters. The position peaked at $130K in Q2 2015. 7 funds tracked by Wall St. Rank hold KZIA as of Q4 2016.

Virtu KCG Holdings reported no remaining Kazia Therapeutics position as of Q4 2016 after selling out during the quarter.
Virtu KCG Holdings sold 119 Kazia Therapeutics shares in Q4 2016, an estimated $46K.
Virtu KCG Holdings first reported a position in Kazia Therapeutics in Q4 2013 and held it in 4 quarters.
Virtu KCG Holdings's Kazia Therapeutics position peaked at $130K in Q2 2015.
7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.